Physician Assistant · Hartford, CT
NPI
1275288268
Since 2022
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1075 Asylum Ave
Hartford, CT, 06105
Phone (860) 714-4402
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
271 services
Medicare patients, 2024
66
Average age 66
Drug cost, 2024
$2.1M
3,615 prescriptions
Company payments, 2025
$491
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristina Armistead was code 99214 (office e&m - established), 129 times for 60 patients. In total Kristina Armistead billed 271 services in 9 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 129 | 60 | $84.06 | $11K |
| 95251 Test - Miscellaneous | Office | 68 | 34 | $22.85 | $1,554 |
| 83036 Blood Count | Office | 28 | 21 | $9.52 | $267 |
| 99214 Office E&M - Established | Facility | 21 | 19 | $67.37 | $1,415 |
By year: 2023 $11K for 181 services; 2024 $15K for 271 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 28 | 21 | $9.52 | $267 |
Medicare prescription drug claims, 2024
In 2024, the drug Kristina Armistead prescribed most often to Medicare patients was Ozempic (Semaglutide), with 359 prescriptions and refills. In total Kristina Armistead wrote 3,615 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 359 | 459 | 69 | $424K |
| Mounjaro Tirzepatide | 254 | 288 | 39 | $304K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 228 | 521 | 93 | $29K |
| Metformin Hcl Generic | 219 | 509 | 68 | $1,050 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 217 | 571 | 91 | $25K |
| Tresiba Flextouch U-100 Insulin Degludec | 135 | 347 | 42 | $101K |
| Trulicity Dulaglutide | 134 | 179 | 32 | $178K |
| Jardiance Empagliflozin | 129 | 215 | 25 | $130K |
| Humalog Kwikpen U-100 Insulin Lispro | 118 | 230 | 33 | $29K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 116 | 235 | 43 | $27K |
| Novolog Flexpen Insulin Aspart | 114 | 240 | 35 | $28K |
| Tresiba Flextouch U-200 Insulin Degludec | 112 | 253 | 28 | $135K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 82 | 187 | 29 | $33K |
| Januvia Sitagliptin Phosphate | 74 | 137 | 21 | $77K |
| Gvoke Hypopen 2-Pack Glucagon | 66 | 66 | 45 | $41K |
Brand drugs: 2,531 claims; generic drugs: 549 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristina Armistead $491 ($491 in general payments such as food, travel and fees) from 12 companies. The largest payer was Amgen Inc. with $65.24.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 3 | $65.24 |
| Mannkind Corporation MNKD | 2 | $58.75 |
| Novo Nordisk Inc NVO | 2 | $54.41 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $50.34 |
| Insulet Corporation PODD | 2 | $47.81 |
| Lilly USA, LLC LLY | 2 | $47.77 |
| Xeris Pharmaceuticals, Inc. | 2 | $36.82 |
| Sequel Med Tech, LLC | 2 | $36.64 |
| Recordati_rare_diseases_inc. | 1 | $33.62 |
| CeQur Corporation | 1 | $28.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.